Understanding Tirzepatide Gut Effects Tirzepatide, a dual-agonist for both GLP-1 and GIP (Glucose-dependent Insulinotropic Polypeptide) receptors, offers enhanced efficacy, but its mechanisms still rely heavily on slowing digestion
Early Clinical Results: In two small clinical studies, GLP-1 agonists reduced alcohol consumption and craving in patients with alcohol use disorder and reduced opioid craving by 40% among opioid use disorder patients 5 Bajaj, S
SeekPeptides members get access to personalized support, detailed protocols, and a community of experienced researchers who have navigated these exact challenges
Heine et al., 2005
K., Renzi, G., Piozzi, C., & Ricevuti, G
Always discuss significant side effects or changes in your administration routine with your licensed healthcare provider